AI Biotech Enveda Doubles in Value to $2 Billion
Backed by a former J&J CEO, the startup plans to advance its drug candidates into late-stage trials.
Read the full story at Wall Street Journal Technology ↗
Timeline · 1 report
- 2026-09-23 10:00 · Wall Street Journal Technology
AI Biotech Enveda Doubles in Value to $2 Billion